322 related articles for article (PubMed ID: 22981460)
1. Physiologically based pharmacokinetic model for rats and mice orally exposed to chromium.
Kirman CR; Hays SM; Aylward LL; Suh M; Harris MA; Thompson CM; Haws LC; Proctor DM
Chem Biol Interact; 2012 Oct; 200(1):45-64. PubMed ID: 22981460
[TBL] [Abstract][Full Text] [Related]
2. Physiologically based pharmacokinetic model for humans orally exposed to chromium.
Kirman CR; Aylward LL; Suh M; Harris MA; Thompson CM; Haws LC; Proctor DM; Lin SS; Parker W; Hays SM
Chem Biol Interact; 2013 Jun; 204(1):13-27. PubMed ID: 23603453
[TBL] [Abstract][Full Text] [Related]
3. Toxicology and carcinogenesis studies of sodium dichromate dihydrate (Cas No. 7789-12-0) in F344/N rats and B6C3F1 mice (drinking water studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2008 Jul; (546):1-192. PubMed ID: 18716633
[TBL] [Abstract][Full Text] [Related]
4. Hexavalent chromium reduction kinetics in rodent stomach contents.
Proctor DM; Suh M; Aylward LL; Kirman CR; Harris MA; Thompson CM; Gürleyük H; Gerads R; Haws LC; Hays SM
Chemosphere; 2012 Oct; 89(5):487-93. PubMed ID: 22682893
[TBL] [Abstract][Full Text] [Related]
5. Human health risk and exposure assessment of chromium (VI) in tap water.
Paustenbach DJ; Finley BL; Mowat FS; Kerger BD
J Toxicol Environ Health A; 2003 Jul; 66(14):1295-339. PubMed ID: 12851114
[TBL] [Abstract][Full Text] [Related]
6. Human ingestion of chromium (VI) in drinking water: pharmacokinetics following repeated exposure.
Finley BL; Kerger BD; Katona MW; Gargas ML; Corbett GC; Paustenbach DJ
Toxicol Appl Pharmacol; 1997 Jan; 142(1):151-9. PubMed ID: 9007044
[TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic insights from the NTP studies of chromium.
Witt KL; Stout MD; Herbert RA; Travlos GS; Kissling GE; Collins BJ; Hooth MJ
Toxicol Pathol; 2013 Feb; 41(2):326-42. PubMed ID: 23334696
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of in vivo models for toxicokinetics of hexavalent chromium in the stomach.
Sasso AF; Schlosser PM
Toxicol Appl Pharmacol; 2015 Sep; 287(3):293-8. PubMed ID: 26123277
[TBL] [Abstract][Full Text] [Related]
10. Is hexavalent chromium carcinogenic via ingestion? A weight-of-evidence review.
Proctor DM; Otani JM; Finley BL; Paustenbach DJ; Bland JA; Speizer N; Sargent EV
J Toxicol Environ Health A; 2002 May; 65(10):701-46. PubMed ID: 12028825
[TBL] [Abstract][Full Text] [Related]
11. Improved physiologically based pharmacokinetic model for oral exposures to chromium in mice, rats, and humans to address temporal variation and sensitive populations.
Kirman CR; Suh M; Proctor DM; Hays SM
Toxicol Appl Pharmacol; 2017 Jun; 325():9-17. PubMed ID: 28389273
[TBL] [Abstract][Full Text] [Related]
12. High concentrations of hexavalent chromium in drinking water alter iron homeostasis in F344 rats and B6C3F1 mice.
Suh M; Thompson CM; Kirman CR; Carakostas MC; Haws LC; Harris MA; Proctor DM
Food Chem Toxicol; 2014 Mar; 65():381-8. PubMed ID: 24418189
[TBL] [Abstract][Full Text] [Related]
13. A revised model of ex-vivo reduction of hexavalent chromium in human and rodent gastric juices.
Schlosser PM; Sasso AF
Toxicol Appl Pharmacol; 2014 Oct; 280(2):352-61. PubMed ID: 25151221
[TBL] [Abstract][Full Text] [Related]
14. Ingestion of chromium(VI) in drinking water by human volunteers: absorption, distribution, and excretion of single and repeated doses.
Kerger BD; Finley BL; Corbett GE; Dodge DG; Paustenbach DJ
J Toxicol Environ Health; 1997 Jan; 50(1):67-95. PubMed ID: 9015133
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
16. Comparative toxicogenomic analysis of oral Cr(VI) exposure effects in rat and mouse small intestinal epithelia.
Kopec AK; Thompson CM; Kim S; Forgacs AL; Zacharewski TR
Toxicol Appl Pharmacol; 2012 Jul; 262(2):124-38. PubMed ID: 22561333
[TBL] [Abstract][Full Text] [Related]
17. A chronic oral reference dose for hexavalent chromium-induced intestinal cancer.
Thompson CM; Kirman CR; Proctor DM; Haws LC; Suh M; Hays SM; Hixon JG; Harris MA
J Appl Toxicol; 2014 May; 34(5):525-36. PubMed ID: 23943231
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide gene expression effects in B6C3F1 mouse intestinal epithelia following 7 and 90days of exposure to hexavalent chromium in drinking water.
Kopec AK; Kim S; Forgacs AL; Zacharewski TR; Proctor DM; Harris MA; Haws LC; Thompson CM
Toxicol Appl Pharmacol; 2012 Feb; 259(1):13-26. PubMed ID: 22155349
[TBL] [Abstract][Full Text] [Related]
19. Physiologically based pharmacokinetic modeling of arsenic in the mouse.
Gentry PR; Covington TR; Mann S; Shipp AM; Yager JW; Clewell HJ
J Toxicol Environ Health A; 2004 Jan; 67(1):43-71. PubMed ID: 14668111
[TBL] [Abstract][Full Text] [Related]
20. A physiologically based model for the ingestion of chromium(III) and chromium(VI) by humans.
O'Flaherty EJ; Kerger BD; Hays SM; Paustenbach DJ
Toxicol Sci; 2001 Apr; 60(2):196-213. PubMed ID: 11248132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
